These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21216723)

  • 21. Chiropractic in Global Health and wellbeing: a white paper describing the public health agenda of the World Federation of Chiropractic.
    Maiers M; Agaoglu M; Brown R; Cassirer C; DaSilva K; Lystad RP; Mohammad S; Wong JJ
    Chiropr Man Therap; 2018; 26():26. PubMed ID: 30026909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Can We Improve Osteoporosis Care? A Systematic Review and Meta-Analysis of the Efficacy of Quality Improvement Strategies for Osteoporosis.
    Nayak S; Greenspan SL
    J Bone Miner Res; 2018 Sep; 33(9):1585-1594. PubMed ID: 29637658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
    Adler RA; El-Hajj Fuleihan G; Bauer DC; Camacho PM; Clarke BL; Clines GA; Compston JE; Drake MT; Edwards BJ; Favus MJ; Greenspan SL; McKinney R; Pignolo RJ; Sellmeyer DE
    J Bone Miner Res; 2016 Jan; 31(1):16-35. PubMed ID: 26350171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Bansal S; Pecina JL; Merry SP; Kennel KA; Maxson J; Quigg S; Thacher TD
    Osteoporos Int; 2015 Apr; 26(4):1429-33. PubMed ID: 25614141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The discriminative ability of FRAX, the WHO algorithm, to identify women with prevalent asymptomatic vertebral fractures: a cross-sectional study.
    El Maghraoui A; Sadni S; Jbili N; Rezqi A; Mounach A; Ghozlani I
    BMC Musculoskelet Disord; 2014 Nov; 15():365. PubMed ID: 25366306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
    Watts NB;
    Nat Rev Endocrinol; 2014 Jul; 10(7):412-22. PubMed ID: 24751880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea.
    Yi H; Ha YC; Lee YK; Lim YT
    J Bone Metab; 2013 May; 20(1):17-23. PubMed ID: 24524051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidance for the diagnosis, prevention and therapy of osteoporosis in Italy.
    Cianferotti L; Brandi ML
    Clin Cases Miner Bone Metab; 2012 Sep; 9(3):170-8. PubMed ID: 23289033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of second hip fracture and compliant use of bisphosphonate.
    Lee YK; Ha YC; Yoon BH; Koo KH
    Osteoporos Int; 2013 Jul; 24(7):2099-104. PubMed ID: 23247329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying and managing patients at high risk for fractures: conclusions from the second Spanish multidisciplinary forum-parathyroid hormone use in osteoporotic patients at high risk for fractures.
    Jódar Gimeno E
    Drugs R D; 2012 Dec; 12(4):199-206. PubMed ID: 23193980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.
    Nayak S; Roberts MS; Greenspan SL
    Ann Intern Med; 2011 Dec; 155(11):751-61. PubMed ID: 22147714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2018 update of French recommendations on the management of postmenopausal osteoporosis.
    Briot K; Roux C; Thomas T; Blain H; Buchon D; Chapurlat R; Debiais F; Feron JM; Gauvain JB; Guggenbuhl P; Legrand E; Lehr-Drylewicz AM; Lespessailles E; Tremollieres F; Weryha G; Cortet B
    Joint Bone Spine; 2018 Oct; 85(5):519-530. PubMed ID: 29654947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.
    Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP; Petak SM
    Endocr Pract; 2010; 16(6):1016-9. PubMed ID: 21216723
    [No Abstract]   [Full Text] [Related]  

  • 34. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
    Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP; Petak SM;
    Endocr Pract; 2010; 16 Suppl 3(Suppl 3):1-37. PubMed ID: 21224201
    [No Abstract]   [Full Text] [Related]  

  • 35. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update.
    Watts NB; Camacho PM; Lewiecki EM; Petak SM;
    Endocr Pract; 2021 Apr; 27(4):379-380. PubMed ID: 33577971
    [No Abstract]   [Full Text] [Related]  

  • 36. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.